APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
24 hedge funds and large institutions have $4.71M invested in Aptose Biosciences, Inc. in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.92K | |
| 2 | +$835 | |
| 3 | +$464 | |
| 4 |
CSC
Caldwell Sutter Capital
Sausalito,
California
|
+$427 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$135 |
Top Sellers
| 1 | -$925K | |
| 2 | -$862K | |
| 3 | -$205K | |
| 4 |
VC
Voss Capital
Houston,
Texas
|
-$102K |
| 5 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
-$58K |